Best Stomach cancer doctors: TOP 155 doctors

Fields of Study and Interests

 Breast Cancer

 Lung Cancer

 Colon Cancer

 Stomach Cancer

 Rectum Cancer

 Ovarian Cancer

 Uterine Cancer

 Liver Cancer

 Esophageal Cancer - Esophagus Cancer

 Kidney Cancer

 Larynx Cancer - Throat Cancer

 Thyroid Cancer

 Head and Neck Cancers

 Gynecological Cancers

 Pancreatic Cancer

 Esophageal Cancer - Esophagus Cancer

 Uterine Cancer

 Brain Cancers - Brain Tumors

 Soft Tissue Cancer - Sarcomas

 Prostate Cancer

 Bladder Cancer

 Bile Duct Cancer

 Testicular Cancer

 Cervical Cancer

 Mouth, Tongue, Lip Cancers

 Gastrointestinal System Cancers

 Bone Tumors

 Trachea and Bronchial Cancers

 Skin Cancers - Skin Cancers

 Skeletal System Tumors

 Gallbladder Cancer

 Mesothelioma

Education

 Cumhuriyet University Faculty of Medicine, 2004

 Istanbul Haydarpaşa Education and Research Hospital Internal Medicine Specialist, 2010

 Karadeniz Technical University Faculty of Medicine Medical Oncology Specialist, 2015

Career

 MD Andeson Cancer Center, USA, 2008

 Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017

 Moffit Cancer Center, USA 2022

 Istanbul Haydarpaşa Education and Research Hospital Internal Medicine, 2010

 İdil State Hospital Internal Medicine Clinic, 2011

 Karadeniz Technical University Faculty of Medicine Medical Oncology Clinic, 2015

 Istanbul Göztepe Education and Research Hospital Medical Oncology Clinic, 2018

 Yeniyüzyıl University Gaziosmanpaşa Hospital Medical Oncology Clinic, 2020

 Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Prof. Dr. med. Ulrich Graven

Head of the Clinic of Hematology, Oncology and Gastroenterology

Head of a certified oncology center

Head of Clinical Research Department

Specialization:

Hematology, including stem cell transplantation

Abdominal oncology, especially colorectal and pancreatic cancer therapy

Metastasis therapy, including the use of off-label drugs

Membership in professional societies:

Professional Union of German Therapists

German Society for Internal Medicine

German Cancer Society

Abdominal Oncology Working Group

German Society of Hematology and Oncology

German Working Group on Bone Marrow and Hematopoietic Stem Cell Transplantation

German Society for Digestive and Metabolic Diseases

European Society for Medical Oncology

American Society of Clinical Oncology

American Association for Cancer Research

Activities in professional communities:

German Cancer Society:

Since 2013, speaker of the commission for certification of oncology centers

Since November 2007, member of the board

Since September 2022, Speaker of the Section of National Societies on Cancer Control

Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.

Chairman of the Oncology Society of North Rhine-Westphalia.

Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.

Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.

Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.

Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.

Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.

Member of the committee for the development of clinical guidelines for colorectal cancer.

Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.

Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Dr. Asawadech Sanbua

Medical Radiation​ Oncologist

• Passed palliative care training at the Karunrak Center. Khon Kaen University
  
   
• Certificate of oncotherm
  
   
• Expert in treating cancer with oncothermia machines (or hyperthermia machine) 5 years experience.
  
   
• 14 years of experience working in radiotherapy. Able to plan treatment (Planning 2D, 3D, IMRT, VMAT)
  
   
• Can provide chemical treatment, Chemotherapy, targeted drugs therapy) Immunotherapy (Immunotherapy) 

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

Medical Intrests

• Breast Cancer
• Lung Cancer
• Colon Cancer
• Stomach Cancer
• Rectal Cancer
• Ovarian Cancer
• Liver Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Kidney Cancer
• Larynx Cancer - Cancer of the Larynx
• Thyroid Cancer
• Head and Neck Cancers
• Gynaecological Cancers
• Pancreatic Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Uterine Cancer
• Brain Cancers - Brain Tumours
• Soft Tissue Cancer - Sarcomas
• Prostate Cancer
• Bladder Cancer
• Bile Tract Cancer
• Testicular Cancer
• Cervical Cancer
• Mouth, Tongue, Lip Cancers
• Gastrointestinal System Cancers
• Bone Tumours
• Trachea and Bronchial Cancers
• Skin Cancers - Skin Cancers
• Skeletal System Tumours
• Gallbladder Cancer
• Mesothelioma

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Born in 1978, Specialist Dr. Mustafa Solak graduated from Hacettepe University Faculty of Medicine. He completed his residency at Istanbul Şişli Etfal Training and Research Hospital and received his Sub-specialty from Hacettepe University Cancer Institute.

He has numerous cases related to Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head and Neck Cancers, and Gastrointestinal System Cancers.

MEDICAL INTERESTS

• Breast Cancer
• Testicular Cancer
• Ovarian Cancer
• Lung Cancer
• Head and Neck Cancers
• Gastrointestinal System Cancers

Prof. Dr. Ümmügül Üyetürk completed her undergraduate and graduate education at Uludağ University Faculty of Medicine between 1988-1994. She specialized in Internal Medicine at Istanbul Training and Research Hospital from 1998 to 2003. Between 2008-2011, she received her subspecialty training in Medical Oncology at Ankara Oncology Training and Research Hospital.

After serving as the deputy chief physician at Suluova State Hospital, she established the Internal Medicine Department and Medical Oncology Science Branch at Bolu Abant İzzet Baysal University between 2011-2020, where she served as the head of the science branch. During this time, she educated resident doctors and students. Üyetürk, who received the title of Associate Professor in 2014, spent 6 months in Canada/Toronto in 2019. In 2020, she was awarded the title of Professor at Abant İzzet Baysal University.

Üyetürk has published over 60 articles in international peer-reviewed journals and has more than 20 scientific works published in national peer-reviewed journals. She also has over 100 presentations that have been delivered at international and national scientific meetings and published in proceedings books. In addition to her membership in the European Society for Medical Oncology, she has memberships in medical oncology associations within the country. She has received more than 10 awards given to her at universities and congresses.

MEDICAL INTERESTS

• Prostate Cancer and Urological Cancers
• Lung Cancer
• Gastrointestinal System Cancers
• Breast Cancer
• Ovarian, Endometrial, and Cervical Cancers (Genital Cancers)

Assoc. Dr. Görkem TÜRKKAN started his medical education at Gülhane Military Medical Academy in 2003 and completed it in 2009 at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine. He completed his residency in the Department of Radiation Oncology at Trakya University Faculty of Medicine and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Doctor Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology from May 2019 to February 2021. During this period, between March and June 2020, he worked as a clinical researcher in the Department of Radiation Oncology at Maastricht University Medical Center–MAASTRO Clinic (Netherlands) on studies related to stereotactic radiotherapy, thoracic radiation therapy-associated lung toxicity, and proton therapy. Between March 2021 and April 2023, he worked at the Radiation Oncology Department of Istinye University Faculty of Medicine and Liv Hospital Ulus Radiation Oncology Clinic, where he received the title of Associate Professor in February 2023. He has been providing services to his patients at Hisar Hospital Intercontinental since May 2023.

Throughout his professional life, he has performed both traditional and advanced radiotherapy practices. Particularly, he is one of the experienced physicians in Turkey in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which are gaining popularity and usage recently. So far, he has successfully completed over 2500 radiotherapy sessions using the MR-Linac device.

Since 2013, he has been a member of the Turkish Radiation Oncology Society (TROD) and since 2015 a member of the European Society for Radiotherapy and Oncology (ESTRO). He has 27 published articles in national and international journals, 31 oral-poster presentations at national and international congresses, and 5 book chapters published by national and international publishers. He has taught undergraduate courses in Period I and Period V at Muğla Sıtkı Koçman University Faculty of Medicine, master’s courses within the ENT Department Specialist training, and Radiation Therapy associate degree courses at Istinye University Health Services Vocational School. He is currently involved in 2 ongoing TÜBİTAK Projects. He is married and has one son.

MEDICAL INTERESTS

• MR-Linac
• Linac
• Stereotactic (Precision) Radiotherapy
• Prostate Cancers
• Breast Cancers
• Lung Cancers
• Rectal Cancers
• Brain and Spinal Cord Cancers
• Head and Neck Cancers
• Volumetric Arc Therapy (VMAT)
• Intensity-Modulated Radiation Therapy (IMRT)
• 
   

Prof. Kıvanç Derya Peker completed his medical education and general surgery specialization at Istanbul University Istanbul Faculty of Medicine (Çapa). After his major specialization, he got his Gastroenterology Surgery Specialization from the Gastroenterology Surgery Clinic of Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital by entering the top 3 in the minor examination.

During his sub-branch assistantship, he received a scholarship from the Turkish Surgery Association and worked at Mayo Clinic (Rochester, USA) Hepatopancreatobiliary Surgery Clinic and Obesity-Metabolic Surgery Clinic. After returning to Turkey, He was one of the founders of the Hepatopancreatobiliary Surgery unit at Bakırköy Dr. Sadi Konuk Training and Research Hospital. Peker provided Hepatopancreatobiliary Surgery training to general surgery residents and gastroenterology surgery residents in this hospital, which is accepted as a training unit by the Turkish HPB Association.

On the other hand; In order to learn stem cells, cancer biology, cellular properties of obesity and aging, he did his doctorate and thesis on aging at Istanbul University, Istanbul Faculty of Medicine (Çapa), Department of Medical Biology. Then, he moved to Başakşehir Çam and Sakura City Hospital to establish the Gastroenterology Surgery Clinic.

Especially in his career; He is interested in Pancreatic Diseases and Surgery, Gallbladder and Bile Duct Diseases Surgery, Liver Cancer Surgery, Stomach Cancer Surgery and Obesity-Metabolic Surgery. Peker has carried out many successful operations. He has performed over 400 pancreatic and gastric cancer surgeries, over 200 liver surgeries, many surgeries related to gallbladder and biliary tract diseases, obesity – metabolic surgery and endoscopic treatments, and kidney transplants so far. He is also interested in aging and stem cell treatments.

MEDICAL INTERESTS

• Pancreatic Surgery
• Gallbladder and Tracts Surgery
• Liver Diseases Surgery
• Stomach Diseases and Stomach Cancer Surgery
• Obesity – Metabolic Surgery and Endoscopic Treatments
• Kidney Transplant

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Education & Specialization

• 1994 to 2000 – Çukurova University Faculty of Medicine
• 2002 to 2006 – Dicle University Faculty of Medicine, Medical Specialization in General Surgery
• 2008 to 2010 – İstanbul Koşuyolu High Specialization Hospital, Gastroenterology Surgery Sub-Specialization

Work Experience

• Çukurova University Faculty of Medicine
• Dicle University Faculty of Medicine – Medical Specialization in General Surgery
• Kahta State Hospital – General Surgery Specialist
• İstanbul Koşuyolu High Specialization Hospital – Gastroenterology Surgery Sub-Specialist
• Çanakkale 18 Mart University, Department of General Surgery Faculty Member

Professional Memberships

• -Turkish Surgical Association
• -Gastroenterology Surgery Association

Scientific Publications

Scientific Publications

L-Carnitine has a protective effect on the colonic mucosa during abdominopelvic radiotherapy in rats – Acta Cirúrgica Brasileira

Preoperative local staging of colorectal cancer patients with MDCT – Hepato-gastroenterology

The effect of amifostine on bacterial translocation after radiation-induced acute enteritis – Acta Cirúrgica Brasileira

In Vitro Effects of Pantoprazole on Contractile Tone and Contraction Frequency of Rat Pyloric Sphincter – Latin American Journal of Pharmacy

Endovascular treatment of delayed hemorrhage developing after pancreaticoduodenectomy – Wiener Klinische Wochenschrift

Perianal Giant Condyloma Acuminatum (Buschke‐Löwenstein Tumor): A Case Report – Case Reports in Surgery

Management of flap dehiscence after Limberg procedure for recurrent pilonidal disease using NPWT – ABCD Arquivos Brasileiros de Cirurgia Digestiva

Isolated omental panniculitis: Two case reports and review of literature – European Journal of General Medicine

The Effect of Endobag Usage on Port Site Infection During Laparoscopic Cholecystectomy

Benign pneumoperitoneum after diagnostic colonoscopy: Case Report – Turkish Journal of Colorectal Disease

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.